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eighing the Risks and Benefits of Cardiac
maging With Ionizing Radiation
homas C. Gerber, MD, PHD,* Raymond J. Gibbons, MD†
acksonville, Florida; and Rochester, Minnesota
he potential risk of fatal malignancy related to cardiac imaging with ionizing radiation is frequently
iscussed in themedical literature and in the lay press. Cliniciansmustweigh this risk against the potential
enefits of cardiac imaging, which are typically not considered in these reports about radiation risk. This
eview summarizes the evidence regardingboth the radiation risks and clinical benefits of cardiac imaging
o provide guidance to the clinician in specific clinical scenarios. Choosing the right test for the right
atient, and performing it with the lowest possible radiation dose, remains a challenge. (J Am Coll
ardiol Img 2010;3:528–35) © 2010 by the American College of Cardiology Foundationt
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ical Ihe rapid recent growth of medical imaging in
linical practice has heightened concerns about
he medical radiation dose received by patients
1). Although it is critical that the health risks
f radiation exposure be carefully weighed
gainst the potential benefits of medical imag-
ng with modalities that use ionizing radiation,
n most of the existing literature the investiga-
ors focus on either the risks or the benefits and
nly rarely consider both (2). Given the exist-
ng uncertainty regarding the carcinogenic po-
ential of ionizing radiation at the doses used in
ardiovascular computed tomography (CT)
nd nuclear cardiology, the “first do no harm”
rinciple argues that responsible clinicians
hould use these imaging modalities only in
ituations in which the clinical benefit can be
xpected to exceed the potential harm. To
acilitate an understanding of the elements
equired for such an appraisal, this viewpoint
ill summarize current concepts about the
otential risks of radiation and relate these risks
rom the *Division of Cardiovascular Diseases and Department of R
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, M
ardiovascular Clinical Studies (WOMEN study); Lantheus Medanuscript received March 11, 2010, accepted March 16, 2010.o the known or expected benefits of cardiac
maging in specific clinical scenarios.
pidemiology Data onMedical
adiation Exposure
ccording to a recent report by the National
ouncil on Radiation Protection and Measure-
ents (3), the per-capita effective radiation
ose of the U.S. population from all sources
ncreased 72% from the early 1980s to 2006,
rimarily as the result of a 5.7-fold increase
rom medical imaging. Background radiation,
hich accounted for approximately 50% of the
er-capita effective dose of the U.S. population
n 2006, changed little during this time.
The increase in medical radiation dose is
argely related to the increased use of imaging
rocedures that involve high radiation doses.
verall, all radiographic, and conventional and
nterventional fluoroscopic procedures together
epresented 25% of the collective dose from
ontherapeutic radiation in 2006. CT repre-
ology, Mayo Clinic, Jacksonville, Florida; and the
sota. Dr. Gibbons has served as a consultant for
maging; and Molecular Insight Pharmaceuticals.
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529ented 49%, and nuclear medicine 26%, of the
ollective dose. Therefore, our discussion will focus
n these 2 modalities.
The number of CT studies in general increased
y 10% to 11% per year between 1993 and 2006.
ccording to the National Council on Radiation
rotection and Measurements report, there were
.1 million cardiac CT studies in 2006, which
epresented 4.7% of all CT studies and 12.1% of the
ollective radiation dose from CT. There were 18.1
illion nuclear medicine studies in 2006, a 4.6-fold
ncrease from 1982. Cardiac nuclear medicine stud-
es had the greatest growth. In 2005, cardiac studies
epresented 57% of all nuclear medicine patient
isits and 85% of the collective radiation dose
eceived from nuclear medicine studies.
A large proportion of this diagnostic (nonthera-
eutic) medical radiation was delivered in specific
ettings or specific subgroups. For example, 82% of
he CT procedures were performed in hospital
aboratories. In 2003, 71% of the cardiac nuclear
edicine procedures were performed in patients
lder than 55 years of age (3).
isk of Cancer From Low-Dose Radiation
stimates of relative risk of fatal cancer related to
onizing radiation are obtained by comparing the
xpected number of cancers with the actually ob-
erved number in specific populations that were
xposed to radiation. In epidemiological human
tudies, increased risk of cancer has not been ob-
erved consistently at “low” effective doses 100
Sv delivered at low dose rates (i.e., over many
ears, as for most patients undergoing medical
maging). The estimates for cancer risk in the
low-dose” range rely on the assumption that the
elationship between the relative risk of cancer and
ffective dose estimates, observed over decades in
apanese survivors of the atomic bomb explosions
who had whole-body exposures at high dose rates),
xtends linearly and without any threshold to pa-
ient populations of various ethnicities undergoing
edical imaging (who receive partial-body irradia-
ion of much lower doses and dose rates). This
linear no-threshold” (LNT) model is considered by
any of the organizations that deal with radiation
rotection as the model best fitting the available
ata on the relationships between radiation dose
nd lifetime-attributable risk (LAR) of cancer (4).
owever, other experts (5) recommend against theuantitative estimation of health risks at low doses meffective dose 50 mSv in 1 year or 100 mSv
ver a lifetime).
The probability of chromosomal changes that
ould translate into phenotypic cancer increases
ith the rate of cell proliferation, number of future
ivisions, and the degree of differentiation of the
ells in question (6). Younger patients are consid-
red to be at greater risk of developing radiation-
elated cancer because their cells are more sensitive
o radiation (as a result of a greater number of future
ivisions) than those of older patients and because
hey are more likely to live through the latency
eriod of 10 to 40 years for most radiation-induced
olid cancers. In the specific case of cardiac imaging,
omen are considered at greater risk of radiation-
nduced cancer than men because of the radiosen-
itivity of their breasts and lungs (4,7). The effects
f age and sex are evident by comparing the LAR
stimated based on the LNT model in hypothetical
atients undergoing a typical coronary CT angio-
ram performed without dose-sparing algorithms
effective dose of 21 mSv for women and 15 mSv for
en) (8). The LAR of 0.7% (1 in 143) for a
0-year-old woman is nearly 16 times greater than
hat of 0.044% (1 in 2,273) for an 80-year-old man.
he “effective dose” (9) accounts for the body parts
xposed to radiation and for the type of radiation
eing used; LARs derived from specific effective
ose values do not therefore differ between the
maging modalities that expose patients to different
orms of ionizing radiation.
Given the large number of scans being per-
ormed, the potential for increased death rates due
o radiation-induced cancer in the population at
arge is of concern. For example, the investigators of
ne study (10) based on the LNT model estimated
hat 29,000 future cancers (two-thirds in women)
ould potentially occur as a result of CT scans
erformed in the U.S. in 2007.
There are several important caveats regarding the
ssessment of relative risk of radiation-induced
ancer (9). First, the effective dose typically used to
xpress risk is a generic estimate that pertains to
athematical models of the human body and can-
ot be applied to individual patients. Effective dose
stimates for cardiac imaging tests are available
rom various sources (1,3,9,11,12). Determining
ndividualized, patient-specific estimates of radia-
ion dose (and risk) is very complex, rarely done,
nd imperfect (9).
Second, omnipresent background radiation,
hich averages 3.6 mSv per year in the U.S., may
ake a contribution to the incidence of cancer in
t
a
v
r
t
o
t
F
f
(
a
d
r
F
r
b
f
p
p
t
o
l
w
e
a
e
e
p
(
b
b
8
(
d
t
a
o
c
y
p
c
a
r
m
h
B
T
w
t
e
i
a
i
c
p
c
n
p
l
i
a
e
a
v
o
i
(
d
t
l
u
r
t
(
d
Epidemio
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 5 , 2 0 1 0
M A Y 2 0 1 0 : 5 2 8 – 3 5
Gerber and Gibbons
Risks and Benefits of Imaging With Ionizing Radiation
530he general population because it affects patients at
ll ages, including children, who are the most
ulnerable. Background radiation primarily is due to
adon exposure in buildings, radioactive elements in
he soil, and cosmic radiation from outer space, all
f which vary in different regions of the country.
Third, the intrinsic risk of cancer is much greater
han the potential risk of radiation-induced cancer.
or example, the intrinsic lifetime risk of dying
rom malignancy in the U.S. is approximately 21%
13). By comparison, the 10 mSv of ionizing radi-
tion from a typical coronary CT angiogram with
ose-sparing algorithms could add 0.05% to that
isk in absolute terms (a relative increase of 0.2%).
igure 1 shows an example for the magnitude of the
elative contributions of natural cancer incidence,
ackground radiation, and the radiation dose received
rom an annual 1-day 99mTc sestamibi myocardial
erfusion study (40 mCi corresponding to 12 mSv;
erformed every year for 40 years beginning at age 40)
o the cumulative cancer incidence in women.
Finally, the statistical power of the available
bservational studies of populations exposed to
ow-dose radiation is generally too low to exclude
ith certainty the possibility of “zero risk” from the
rror bars of the point estimates for solid cancers
nd most forms of leukemia (Fig. 2) (14). For
xample, to quantify the risk of cancer related to an
ffective dose of 10 mSv, a sample size of 5,000,000
atients with lifetime follow-up might be required
0
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Sestamibi 40 mCi (Annually from age 40-80 yrs)
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Cumulative Incidence of Cancer in Women
e cancer incidence (expressed as cases per 100,000 women) that
tributed to background radiation (3 mSv), an annual dose of 40
chnetium-99m sestamibi from age 40 to 80 years, and naturally
cancer. Data are based on the excess absolute risk model from
ic Effects of Ionizing Radiation VII report. SEER  Surveillance,
logy and End Results. Figure courtesy of Michael O’Connor, PhD.15). In contrast, the Life Span Study of atomic iomb survivors, on which the LNT model is largely
ased, has to date reported 47 years of follow-up in
6,572 people with a mean dose of 200 mSv
delivered at a very high dose rate) (16).
In studies of radiation workers (14,17,18), stan-
ardized mortality rates are less in the workers than
hose in the general population, which has been
ttributed to a “healthy worker effect.” One cohort
f more than 407,000 radiation workers in 15
ountries has been extensively studied over many
ears (17,18). The latest report after 5.2 million
erson-years of follow-up (18) suggests that all-
ause mortality within the cohort (mainly related to
n increased risk for cancer) was associated with
adiation dose. However, this study cohort is 90%
en, and the role of smoking in the unexpectedly
igh lung cancer mortality is not clear.
enefits of Cardiac Imaging
hese potential risks of low-dose radiation must be
eighed against the benefits of cardiac imaging. For
his discussion, we will focus on single-photon
mission computed tomography (SPECT) because
t has the most substantial evidence base (19)
mong the high-dose, rapid-growth cardiac imag-
ng modalities (3).
Conceivable benefits of cardiac imaging include
orrect diagnosis, accurate prognostication, and im-
rovement of patient outcomes. Such outcomes
ould include appropriate refocus on alternative
oncardiac diagnoses (e.g., in patients with chest
ain and normal SPECT studies), improved quality of
ife (e.g., attributable to relief of chest pain), and
mproved survival. Patients with high risk of disability
nd death from cardiovascular disease have the great-
st potential absolute gain from appropriate diagnosis
nd management. This risk varies with age, cardio-
ascular risk factors, symptoms, and previous evidence
f coronary artery disease (CAD) (i.e., myocardial
nfarction or revascularization) (20,21).
In symptomatic patients, the ability of stress
either exercise or pharmacologic) SPECT myocar-
ial perfusion imaging (MPI) to diagnose poten-
ially treatable coronary artery disease is well estab-
ished. For example, in patients who have
ninterpretable baseline electrocardiograms as the
esult of pre-excitation or left bundle branch block,
here is a class I recommendation for SPECT MPI
evidence and/or general agreement that the proce-
ure is beneficial, useful and effective) in the Amer-500
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531merican Heart Association (AHA) Guidelines for
he management of chronic stable angina (22).
The use of SPECT MPI also can help establish the
rognosis of patients with CAD. For example, the risk
f cardiac death or myocardial infarction increases as
he overall size of myocardial perfusion defects on
PECT MPI increases and left ventricular ejection
raction (which can be determined from gated images)
ecreases (23). The ACCF/AHA guidelines include
everal class I indications for the use of SPECT MPI
n risk stratification (22).
However, the definition of diagnosis or prognosis
oes not necessarily imply improved outcomes in
erms of patient survival, except in certain sub-
roups of patients. A potential survival benefit
onveyed by cardiac imaging is very relevant to our
iscussion because it must be balanced against the
rojected risk of reduced longevity from cancer.
lthough some radiation-related cancers (leukemia,
hyroid cancer, bone cancer) can have short latency
eriods of 2 to 5 years, most solid cancers have
atency periods of 10 to 40 years.
In comparison, approximately one-half of pa-
ients with 3-vessel CAD and abnormal left ven-
ricular function will die within 5 years with medical
herapy. Because these patients would not otherwise
urvive the latency period of a radiation-induced
ancer, cardiac imaging with ionizing radiation can
e used to identify these patients and thereby
mprove their management and longevity. The
robabilities of either adverse outcome will vary
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Figure 2. Trends in Relative Risk for Solid Cancers in the Nation
Shown are point estimates and 90% conﬁdence intervals (CI) for rel
than 170,000 radiation workers by lifetime radiation dose. The CIs a
no increased risk. BEIR VII  Biological Effects of Ionizing Radiation
permission, from Muirhead et al. (14).reatly for specific clinical scenarios, but in thehort-term (e.g., 5 years) the risk from CAD is
enerally far greater than the risk from radiation-
nduced cancer.
The use of cardiac imaging in symptomatic
atients is largely based on the assumption that it
ill improve outcomes. This assumption is proven
nly for small, selected subgroups of patients in
hom very severe disease such as left main stenosis
s detected. There are no randomized trials to show
hat patients with chronic stable angina who are
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NRRW linear fit
NRRW upper and lower limits of 90% CI
egistry for Radiation Workers
e risk of all malignant neoplasms excluding leukemia in more
ses less than 200 mSv include a relative risk of 1, consistent with
NRRW  National Registry for Radiation Workers. Reprinted, with
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Figure 3. Patient Outcomes With Medical Therapy and Revascu
at Varying Degrees of Myocardial Ischemia
Log relative hazard ratio for revascularization (Revasc) versus medical t
(Rx) as a function of percent ischemic myocardium based on ﬁnal Cox
tional hazards model. If more than 10% of the total myocardium is isc
the survival beneﬁt for revascularization over medical therapy increase
function of increasing proportion of ischemic myocardium. Model p Dos
I
al R
ativ
t do
VII;50%
edical Rx
evasc
larization
herapy
propor-
hemic,
s as a
0.0001.Reprinted, with permission, from Hachamovitch et al. (25).
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532andomized to cardiac stress imaging have better
utcomes than similar patients who are managed
ithout “guidance” by noninvasive cardiac imaging.
owever, the ability of cardiac imaging to improve
atient outcomes is supported by observational
ata. In retrospective analyses, symptomatic pa-
ients with no previous history of CAD who have
oderate-to-large amounts of inducible ischemia
n SPECT MPI have greater absolute and relative
hort-term survival benefit with revascularization
han with medical therapy (Fig. 3). Conversely,
atients with no or small amounts of ischemia
ave better survival with medical therapy (24).
he degree of ischemia predicts survival benefit
rom revascularization compared with medical
herapy better than the left ventricular ejection
raction after stress measured on gated SPECT
tudies (25).
The use of serial stress imaging studies in the
ollow-up of many patients with chronic, stable,
ymptomatic coronary artery disease is of less certain
enefit. Such studies may lead to cardiac catheteriza-
ion guided by cine-fluoroscopy, with additional radi-
tion exposure. The incidence and benefit of coronary
Table 1. Risks and Beneﬁts of Cardiac Imaging With Ionizing Ra
Risk of radiation-induced cancer
1. At radiation doses used in medical imaging, cancer risk is proje
no-threshold model
2. True risk of radiation-related cancer at low (100 mSv) dose m
A. Individualization of radiation dose and risk is difﬁcult and im
B. Background radiation is omnipresent
C. Radiation-related cancers are biologically indistinguishable fr
D. Risk of intrinsic cancer is high relative to low projected risk
E. Appropriately powered observational studies of lifetime-attri
impossible
3. Latency period for most solid radiation-related cancers is 10–4
4. Projected lifetime-attributable risk is greater for younger than
Possible beneﬁts of cardiac Imaging
1. Symptomatic patients
A. Correct diagnosis
a. Choice of disease-speciﬁc therapy
b. Improved quality of life by relief of symptoms
B. Prognostication
C. Improved outcomes (survival)—selected subjects
2. Asymptomatic patients
A. Improved survival—unproven
Weighing risks and beneﬁts
1. Missing the right diagnosis in symptomatic patients by avoidin
2. Improved quality of life due to optimized therapy is difﬁcult to
3. Improved survival due to optimal therapy vs. possible decrease
4. Beneﬁt/risk ratio greater in symptomatic patients, high-risk pat
5. Current evidence does not support imaging with ionizing radia6. Beneﬁt/risk ratio is improving as technical developments facilitateevascularization prompted by stress imaging studies
n such patients requires further study.
The benefit of imaging in asymptomatic patients
s far more speculative. Noninvasive cardiac imag-
ng lacks important characteristics of a mature
arker of cardiovascular risk in asymptomatic pa-
ients (26). The observed versus expected event
ates across the range of predicted risk for models
ith and without imaging, the number of subjects
eclassified across risk thresholds with the use of
maging, and the event rates of these subjects are
ot well established. The ACCF and AHA guide-
ines generally have not endorsed the use of imaging
n asymptomatic individuals to detect CAD. The
HA has given a class IIb recommendation, i.e., “may
e considered,” to coronary artery calcium scoring
ith CT in intermediate-risk patients, but recom-
ends against (class III recommendation) calcium
coring in either low-risk or high-risk patients (27,28).
ther imaging, such as SPECT and CT coronary
ngiography, also has not been recommended. A new
CCF/AHA clinical practice guideline regarding the
etection of asymptomatic coronary disease is sched-
led for publication in 2010.
tion
d (but not known with certainty) on the basis of the linear
never be known
fect
intrinsic cancer
diation-induced cancer
ble risk of cancer related to low-dose radiation are logistically
ars
lder patients and greater for women than for men
aging is a risk
antify
survival from radiation-induced cancer
s, older individuals, and men
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533In asymptomatic patients, there can be no im-
rovement in quality of life or symptoms; therefore,
he only conceivable benefit of imaging is improved
utcomes such as survival. The hypothesis that
argeted, tailored, aggressive risk management
ased on the “early” recognition of subclinical CAD
ill improve outcomes is not proven. Several im-
ortant studies published in 2009 are pertinent to
his issue. In the DIAD (Detection of Ischemia in
symptomatic Diabetics) study, investigators ex-
mined the use of adenosine stress SPECT imaging
or CAD screening in 1,123 asymptomatic diabetic
atients. The cumulative cardiac event rates aver-
ged only 0.6% per year. Although participants with
oderate or large perfusion defects had greater
vent rates than those with small perfusion defects
r normal SPECT studies, the use of SPECT for
creening did not improve patient outcomes.
In the National Heart, Lung and Blood
nstitute-sponsored BARI-2D (Bypass and Angio-
lasty Revascularization in Diabetics) study, inves-
igators randomized mildly symptomatic or asymp-
omatic diabetic patients to either revascularization
r medical management based in part on stress
maging. Revascularization was not associated with
mproved outcomes. Thus, neither current clinical
ractice guidelines nor the emerging evidence sup-
ort the use of any cardiac imaging, with or without
adiation, in asymptomatic individuals. This in-
ludes asymptomatic diabetic patients, i.e., those
ho were thought to most likely benefit from
creening because they had greater event rates than
symptomatic individuals without diabetes (29).
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Figure 4. Reduction of Radiation Dose From Cardiac Computed
Distribution of patients by their estimated radiation dose during co
improvement effort in 15 Michigan imaging centers. Reprinted, with peractical Considerations
hat are the implications for the evidence-based
linician? Our view of the conceivable risks and
enefits of cardiac imaging with modalities that use
adiation is summarized in Table 1. In the absence
f any proven benefit, the small projected LAR of
ancer argues against the widespread use of SPECT
r CT angiography in asymptomatic individuals but
ven more so does their cost, which is beyond the
cope of this discussion (30).
However, we believe that the situation in symp-
omatic patients is far different. In these patients,
he weight of evidence supports benefits from car-
iac imaging which far outweigh the small pro-
ected risk of radiation-induced cancer. Patients
ho undergo imaging for diagnosis and risk strat-
fication of coronary disease are predominantly men
ho often are older than 60 years of age. These
atients are much more likely to die of illnesses,
ncluding CAD, rather than radiation-induced can-
er during the remainder of their expected life span.
nfortunately, this important concept is often lost
n the controversy surrounding asymptomatic indi-
iduals among health-care professionals and the
edia coverage of radiation risk in the lay press.
What are the implications for health-care profes-
ionals performing cardiac imaging? Although the
isk of radiation-induced cancers at the dose levels
sed in cardiac imaging is very low, it may not be
ero. Considering the endorsement of the LNT
odel by most consensus committees of radiation
afety protection experts, it is rational to perform all
25 30 35 40 45 ≥45
ose (mSv)
trol Period (July 2007-August 2007; n=620)
ow-up Period (May 2008-June 2008; n=835)
ographic Angiography by Education on a Best Practice Model
ted tomography coronary angiography before and after a qualityn D
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534maging studies at the lowest possible radiation
ose that is consistent with obtaining diagnostic
mage quality (9). Medical errors that lead to
xcessive radiation doses (31) must be avoided. The
uthors of several studies (32–34) have shown that
he radiation dose received from cardiac CT varies
reatly between different imaging centers, even in the
bsence of medical error. Appropriate education on
est-practice models can decrease the radiation dose
y more than 50% (Fig. 4) (33). Such education efforts
ust become more widespread; they should be sup-
orted by professional organizations through educa-
ion regarding radiation risk and the safety and pro-
otion of standardized, low-dose imaging protocols
35) to guide responsible clinical practice.
New imaging techniques and equipment will allow
urther substantial reductions in the radiation dose
eceived from both cardiac CT (36) and SPECT (37)tion 103). Ann ICRP 2007;37:1–332. RGE, et al. Mortali38,39). These developments will greatly modify the
risk” aspect of cardiac imaging with ionizing radia-
ion but will not resolve the broader concerns about
he appropriateness of the tremendous growth in
ardiac imaging, particularly in patient groups who are
nlikely to benefit in terms of outcomes and survival.
he Center for Medicare and Medicaid Services has
tarted planning a pilot study of imaging appropriate-
ess, which was legislatively mandated by Congress in
008. Appropriately choosing the right test for the
ight patient and performing it with the lowest-
ossible radiation dose to the patient remains a chal-
enge, both to those who order imaging studies and
hose who perform them.
eprint requests and correspondence: Dr. Raymond J.
ibbons, Mayo Clinic, 200 First Street, SW, Rochester,without appreciable effect on diagnostic accuracy Minnesota 55905. E-mail: gibbons.raymond@mayo.edu.1
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